NEW STRATEGIES

Rome, 2-3 December 2016

 

Topics

Biological footprint: crossing biochemical, immunological and molecular indexes against clinical data

Prognosis of vitiligo  and biomarkers

Outcome research, including PRO: preparing the future RCTs in Vitiligo

New therapeutic targets 

Management of  vitiligo:  physician’s and patient’s perspectives

Clinical and experimental studies and educational case reports.